Morgan Stanley Downgrades Bright Health Gr to Equal-Weight, Lowers Price Target to $5
Morgan Stanley analyst Ricky Goldwasser downgrades Bright Health Gr (NYSE:BHG) from Overweight to Equal-Weight and lowers the price target from $13 to $5.